Detalles de la búsqueda
1.
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Int J Cancer
; 147(2): 413-422, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31714586
2.
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
Invest New Drugs
; 38(6): 1774-1783, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410080
3.
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
Cancer Sci
; 110(4): 1340-1351, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724423
4.
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
Immunity
; 29(1): 79-89, 2008 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-18571443
5.
The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
J Immunol
; 194(8): 3567-82, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25786692
6.
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 141(1): 43-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27016228
7.
Young people's decisions about biologic therapies: who influences them and how?
Rheumatology (Oxford)
; 54(7): 1294-301, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661469
8.
Dosage uniformity problems which occur due to technological errors in extemporaneously prepared suppositories in hospitals and pharmacies.
Saudi Pharm J
; 22(4): 338-42, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25161378
9.
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial.
J Clin Oncol
; 42(2): 180-191, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788412
10.
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
Cancer
; 119(21): 3776-83, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24037752
11.
Efficient delivery of the toll-like receptor agonists polyinosinic:polycytidylic acid and CpG to macrophages by acetalated dextran microparticles.
Mol Pharm
; 10(8): 2849-57, 2013 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23768126
12.
Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.
Pharm Res
; 30(5): 1349-61, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23354770
13.
Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.
Proc Natl Acad Sci U S A
; 107(12): 5652-7, 2010 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20231466
14.
Ultra-fast pg/ml anthrax toxin (protective antigen) detection assay based on microwave-accelerated metal-enhanced fluorescence.
Anal Biochem
; 425(1): 54-61, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22406431
15.
Correction: The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell-Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9-Producing T Cells.
J Immunol
; 195(12): 5839-40, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26637663
16.
Model-based dose selection to inform translational clinical oncology development of WNT974, a first-in-class Porcupine inhibitor.
Clin Transl Sci
; 15(7): 1713-1722, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35620969
17.
Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment.
CPT Pharmacometrics Syst Pharmacol
; 11(8): 1122-1134, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35728123
18.
Integration of Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy into Model-Informed Dose Selection in Oncology First-in-Human Study: A Case of Roblitinib (FGF401).
Clin Pharmacol Ther
; 112(6): 1329-1339, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36131557
19.
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma.
Gynecol Oncol Rep
; 40: 100974, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35434236
20.
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.
J Exp Clin Cancer Res
; 41(1): 189, 2022 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35655320